Azithromycin Treatment vs Placebo in Children With Respiratory Syncytial Virus–Induced Respiratory Failure: A Phase 2 Randomized Clinical Trial

IMPORTANCE: Despite a high disease burden, there is no effective treatment for respiratory syncytial virus (RSV) infection. OBJECTIVES: To determine whether administration of azithromycin (AZM) to children with RSV-induced respiratory failure is safe and to define the effect of AZM therapy on nasal...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Michele, Zhang, Wei Wei, Sewell, Kate, Gorman, Gregory, Kuo, Hui-Chien, Aban, Inmaculada, Ambalavanan, Namasivayam, Whitley, Richard J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7180420/
https://www.ncbi.nlm.nih.gov/pubmed/32324238
http://dx.doi.org/10.1001/jamanetworkopen.2020.3482

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7180420/
https://www.ncbi.nlm.nih.gov/pubmed/32324238
http://dx.doi.org/10.1001/jamanetworkopen.2020.3482

Ejemplares similares